Escitalopram

Overview

4.6 out of 5 (56 Reviews)

Credits

1.00

Post Assessment Questions

7

Start Date

1 Sep 2023

Last Review Date

10 Nov 2023

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6669 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7920 hours of CE.

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$59 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$79 per 1 year per user
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Escitalopram, the (S)-enantiomer of citalopram, is a highly selective serotonin reuptake inhibitor. Escitalopram is approved by the U.S. Food and Drug Administration (FDA) for treating major depressive disorder (unipolar) in adults and adolescents (ages 12 to 17) for both acute and maintenance phases. The FDA recently approved escitalopram for the treatment of generalized anxiety disorder in both adults and children aged 7 and older. Escitalopram is also used off-label for conditions such as social anxiety disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, premenstrual dysphoric disorder, and the management of vasomotor symptoms associated with menopause. Safe and effective treatment of escitalopram requires an understanding of its potential adverse effects and drug interactions. This activity outlines the clinical applications, mechanisms of action, possible adverse effects, and drug interactions of escitalopram to help interprofessional healthcare providers direct patient therapy in treating various conditions. This activity also emphasizes the importance of vigilant monitoring and making informed decisions by healthcare professionals throughout escitalopram therapy, facilitating early detection and intervention to ensure patient safety and provide optimal care.


UAN: JA4008338-0000-23-027-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the appropriate clinical indications for escitalopram, including FDA-approved uses and off-label applications.

  • Assess patients regularly for adverse effects, therapeutic response, and potential drug interactions while on escitalopram.

  • Select appropriate treatment for depression and anxiety, including escitalopram, based on patient needs.

  • Collaborate with an interprofessional healthcare team to optimize patient care and monitor the use of escitalopram in various clinical settings.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.00 ACPE credit(s). (UAN: JA4008338-0000-23-027-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Shabaz M. on 3/10/2021

Thomas P. on 3/14/2021

Sarah B. on 9/30/2021

Erik D. on 10/23/2021

Michael P. on 12/6/2021

Jeffrey H. on 12/18/2021

Branette Y. on 1/2/2022

Terri C. on 1/4/2022

Mary Y. on 3/27/2022

Michael P. on 4/25/2022

YOUN JU L. on 6/28/2022

Nicole G. on 9/29/2022

jeffrey t. on 12/6/2022

Jade K. on 12/22/2022

Latoya R. on 1/29/2023

jubril o. on 2/11/2023

George G. on 2/17/2023

Jill P. on 2/23/2023

Elizabeth H. on 3/2/2023

Dana P. on 3/14/2023

Lynn J. on 3/15/2023

Cameo J. on 3/16/2023

krista g. on 3/23/2023

Shirley A. on 4/4/2023

Brian B. on 4/10/2023

Quarshiwaa A. on 4/30/2023

Faiza H. on 5/1/2023

coral c. on 5/4/2023

James N. on 5/31/2023

Ali I. on 5/31/2023

Natasha M. on 6/22/2023

Michael P. on 6/5/2023

Sheila C. on 6/18/2023

gilbert b. on 6/18/2023

Melanie G. on 7/31/2023

Kira M. on 8/13/2023

Emily B. on 9/3/2023

Michael S. on 9/19/2023

roxanna g. on 10/4/2023

Linden G. on 10/19/2023

Timothy R. on 10/21/2023

Prevention C. on 11/20/2023

Melissa B. on 12/5/2023

Margaret D. on 1/2/2024

Emily B. on 1/7/2024

Jibril Y. on 2/20/2024

Leah M. on 3/9/2024

Monet I. on 3/26/2024

Joseph G. on 4/9/2024

Corry R. on 4/13/2024

James F. on 6/7/2024

Ashley F. on 6/7/2024

Solomon L. on 6/24/2024

Brianna M. on 6/27/2024

Rex G. on 7/7/2024

Matthew S. on 7/19/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6669 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7920 hours of CE.

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$59 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$79 per 1 year per user